The Biotech Dictionary http://thebiotechdictionary.com Wed, 17 Aug 2011 02:03:21 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 The Essential Biotech Investment Guide: How to Invest in the Healthcare Biotechnology & Life Sciences Sector http://thebiotechdictionary.com/the-essential-biotech-investment-guide-how-to-invest-in-the-healthcare-biotechnology-life-sciences-sector http://thebiotechdictionary.com/the-essential-biotech-investment-guide-how-to-invest-in-the-healthcare-biotechnology-life-sciences-sector#comments Tue, 16 Aug 2011 19:03:19 +0000 domain http://thebiotechdictionary.com/the-essential-biotech-investment-guide-how-to-invest-in-the-healthcare-biotechnology-life-sciences-sector

Posts Related to The Essential Biotech Investment Guide: How to Invest in the Healthcare Biotechnology & Life Sciences Sector

]]> http://thebiotechdictionary.com/the-essential-biotech-investment-guide-how-to-invest-in-the-healthcare-biotechnology-life-sciences-sector/feed 0 Business Development for the Biotechnology and Pharmaceutical Industry http://thebiotechdictionary.com/business-development-for-the-biotechnology-and-pharmaceutical-industry http://thebiotechdictionary.com/business-development-for-the-biotechnology-and-pharmaceutical-industry#comments Tue, 16 Aug 2011 19:03:17 +0000 domain http://thebiotechdictionary.com/business-development-for-the-biotechnology-and-pharmaceutical-industry

Posts Related to Business Development for the Biotechnology and Pharmaceutical Industry

]]> http://thebiotechdictionary.com/business-development-for-the-biotechnology-and-pharmaceutical-industry/feed 0 Technology Transfer in Biotechnology: From Lab to Industry to Production (Advances in Biochemical Engineering Biotechnology) http://thebiotechdictionary.com/technology-transfer-in-biotechnology-from-lab-to-industry-to-production-advances-in-biochemical-engineering-biotechnology http://thebiotechdictionary.com/technology-transfer-in-biotechnology-from-lab-to-industry-to-production-advances-in-biochemical-engineering-biotechnology#comments Tue, 16 Aug 2011 19:03:15 +0000 domain http://thebiotechdictionary.com/technology-transfer-in-biotechnology-from-lab-to-industry-to-production-advances-in-biochemical-engineering-biotechnology Univ. of Hannover, Germany. Presents current research in the area of biochemical engineering/biotechnology. Topics covered include cofactor regeneration at lab scale, parallel reactor systems, high pressure fermentation, metabolic flux analysis, and asymmetric catalysis.]]> Univ. of Hannover, Germany. Presents current research in the area of biochemical engineering/biotechnology. Topics covered include cofactor regeneration at lab scale, parallel reactor systems, high pressure fermentation, metabolic flux analysis, and asymmetric catalysis. ]]> http://thebiotechdictionary.com/technology-transfer-in-biotechnology-from-lab-to-industry-to-production-advances-in-biochemical-engineering-biotechnology/feed 0 Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business http://thebiotechdictionary.com/building-the-case-for-biotechnology-management-case-studies-in-science-laws-regulations-politics-and-business http://thebiotechdictionary.com/building-the-case-for-biotechnology-management-case-studies-in-science-laws-regulations-politics-and-business#comments Tue, 16 Aug 2011 19:03:13 +0000 domain http://thebiotechdictionary.com/building-the-case-for-biotechnology-management-case-studies-in-science-laws-regulations-politics-and-business

Posts Related to Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business

]]> http://thebiotechdictionary.com/building-the-case-for-biotechnology-management-case-studies-in-science-laws-regulations-politics-and-business/feed 0 Plunkett’s Biotechnology Industry Trends and Statistics Brief (Business Brief & Market Research Series) 2010 http://thebiotechdictionary.com/plunketts-biotechnology-industry-trends-and-statistics-brief-business-brief-market-research-series-2010 http://thebiotechdictionary.com/plunketts-biotechnology-industry-trends-and-statistics-brief-business-brief-market-research-series-2010#comments Tue, 16 Aug 2011 19:03:11 +0000 domain http://thebiotechdictionary.com/plunketts-biotechnology-industry-trends-and-statistics-brief-business-brief-market-research-series-2010
These products are intended for business and professional use. Plunkett Research data is especially intended to assist with market research, preparation for sales calls, preparation for job interviews and competitive intelligence. Our data is also ideal for people involved in consulting, marketing and investments. The eBook’s content includes a short discussion section, providing an overview of the industry, as well as a one-page statistics summary that provides industry revenue, employment level and other financial statistics. Especially helpful is the way in which our data enables readers who do not have a business, financial or technology background to readily grasp the fundamentals of a specific industry. Notes: Your purchase includes free, introductory access to the Industry Research Center for this specific business sector on our Plunkett Research Online service. As a purchaser of this BUSINESS BRIEF & MARKET RESEARCH eBook, you may register for complimentary, one week, one-user access to this industry at Plunkett Research Online. We recommend that all purchasers take advantage of this offer in order to receive the full value of your purchase. This access will allow you an in-depth look into a long list of specific industry trends and business statistics. Certain restrictions apply. Only one registration allowed per customer for any industry. Registration requests will be responded to during normal business hours.

“Plunkett Research has built a solid reputation providing industry analysis and research in a diverse spectrum of areas—energy and utilities, finance and investment, health care and biotechnology, and engineering and research to name a few.” American Reference Books Annual
]]>

Posts Related to Plunkett's Biotechnology Industry Trends and Statistics Brief (Business Brief & Market Research Series) 2010

]]> http://thebiotechdictionary.com/plunketts-biotechnology-industry-trends-and-statistics-brief-business-brief-market-research-series-2010/feed 0 From Alchemy To Ipo: The Business Of Biotechnology http://thebiotechdictionary.com/from-alchemy-to-ipo-the-business-of-biotechnology-2 http://thebiotechdictionary.com/from-alchemy-to-ipo-the-business-of-biotechnology-2#comments Tue, 16 Aug 2011 19:03:09 +0000 domain http://thebiotechdictionary.com/from-alchemy-to-ipo-the-business-of-biotechnology-2 "A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."-Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers"From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can."-George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, AmgenWritten by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it.]]> "A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."-Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers"From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can."-George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, AmgenWritten by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it. ]]> http://thebiotechdictionary.com/from-alchemy-to-ipo-the-business-of-biotechnology-2/feed 0 Plant and Crop-based Biofuels and Industrial Biotechnology: Comprehensive World Survey of Biofuel Industries and Processes, Renewable Energy and Resources Roadmap http://thebiotechdictionary.com/plant-and-crop-based-biofuels-and-industrial-biotechnology-comprehensive-world-survey-of-biofuel-industries-and-processes-renewable-energy-and-resources-roadmap http://thebiotechdictionary.com/plant-and-crop-based-biofuels-and-industrial-biotechnology-comprehensive-world-survey-of-biofuel-industries-and-processes-renewable-energy-and-resources-roadmap#comments Tue, 16 Aug 2011 19:03:07 +0000 domain http://thebiotechdictionary.com/plant-and-crop-based-biofuels-and-industrial-biotechnology-comprehensive-world-survey-of-biofuel-industries-and-processes-renewable-energy-and-resources-roadmap
This is a privately authored news service and educational publication of Progressive Management. Our e-books put knowledge at your fingertips, and an expert in your pocket!
]]>
This is a privately authored news service and educational publication of Progressive Management. Our e-books put knowledge at your fingertips, and an expert in your pocket!
]]> http://thebiotechdictionary.com/plant-and-crop-based-biofuels-and-industrial-biotechnology-comprehensive-world-survey-of-biofuel-industries-and-processes-renewable-energy-and-resources-roadmap/feed 0 Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property http://thebiotechdictionary.com/best-practices-in-biotechnology-business-development-valuation-licensing-cash-flow-pharmacoeconomics-market-selection-communication-and-intellectual-property http://thebiotechdictionary.com/best-practices-in-biotechnology-business-development-valuation-licensing-cash-flow-pharmacoeconomics-market-selection-communication-and-intellectual-property#comments Tue, 16 Aug 2011 19:03:04 +0000 domain http://thebiotechdictionary.com/best-practices-in-biotechnology-business-development-valuation-licensing-cash-flow-pharmacoeconomics-market-selection-communication-and-intellectual-property

Posts Related to Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property

]]> http://thebiotechdictionary.com/best-practices-in-biotechnology-business-development-valuation-licensing-cash-flow-pharmacoeconomics-market-selection-communication-and-intellectual-property/feed 0 Biotechnology Valuation: An Introductory Guide (The Wiley Finance Series) http://thebiotechdictionary.com/biotechnology-valuation-an-introductory-guide-the-wiley-finance-series-2 http://thebiotechdictionary.com/biotechnology-valuation-an-introductory-guide-the-wiley-finance-series-2#comments Tue, 16 Aug 2011 19:03:03 +0000 domain http://thebiotechdictionary.com/biotechnology-valuation-an-introductory-guide-the-wiley-finance-series-2 * The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
* Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them
]]> * The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
* Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them
]]> http://thebiotechdictionary.com/biotechnology-valuation-an-introductory-guide-the-wiley-finance-series-2/feed 0 The Global Genome: Biotechnology, Politics, and Culture (Leonardo Book Series) http://thebiotechdictionary.com/the-global-genome-biotechnology-politics-and-culture-leonardo-book-series http://thebiotechdictionary.com/the-global-genome-biotechnology-politics-and-culture-leonardo-book-series#comments Tue, 16 Aug 2011 19:03:00 +0000 domain http://thebiotechdictionary.com/the-global-genome-biotechnology-politics-and-culture-leonardo-book-series In the age of global biotechnology, DNA can exist as biological material
in a test tube, as a sequence in a computer database, and as economically valuable
information in a patent. In The Global Genome, Eugene Thacker asks us to consider
the relationship of these three entities and argues that -- by their existence and
their interrelationships -- they are fundamentally redefining the notion of
biological "life itself."Biological science and the biotech industry are
increasingly organized at a global level, in large part because of the use of the
Internet in exchanging biological data. International genome sequencing efforts,
genomic databases, the development of World Intellectual Property policies, and the
"borderless" business of biotech are all evidence of the global intersections of
biology and informatics -- of genetic codes and computer codes. Thacker points out
the internal tension in the very concept of biotechnology: the products are more
"tech" than "bio," but the technology itself is fully biological, composed of the
biomaterial labor of genes, proteins, cells, and tissues. Is biotechnology a
technology at all, he asks, or is it a notion of "life itself" that is inseparable
from its use in the biotech industry?The three sections of the book cover the three
primary activities of biotechnology today: the encoding of biological materials into
digital form -- as in bioinformatics and genomics; its recoding in various ways --
including the "biocolonialism" of mapping genetically isolated ethnic populations
and the newly pervasive concern over "biological security"; and its decoding back
into biological materiality -- as in tissue engineering and regenerative medicine.
Thacker moves easily from science to philosophy to political economics, enlivening
his account with ideas from such thinkers as Georges Bataille, Georges Canguilhem,
Michel Foucault, Antonio Negri, and Paul Virilio. The "global genome," says Thacker,
makes it impossible to consider biotechnology without the context of
globalism.

]]> In the age of global biotechnology, DNA can exist as biological material
in a test tube, as a sequence in a computer database, and as economically valuable
information in a patent. In The Global Genome, Eugene Thacker asks us to consider
the relationship of these three entities and argues that -- by their existence and
their interrelationships -- they are fundamentally redefining the notion of
biological "life itself."Biological science and the biotech industry are
increasingly organized at a global level, in large part because of the use of the
Internet in exchanging biological data. International genome sequencing efforts,
genomic databases, the development of World Intellectual Property policies, and the
"borderless" business of biotech are all evidence of the global intersections of
biology and informatics -- of genetic codes and computer codes. Thacker points out
the internal tension in the very concept of biotechnology: the products are more
"tech" than "bio," but the technology itself is fully biological, composed of the
biomaterial labor of genes, proteins, cells, and tissues. Is biotechnology a
technology at all, he asks, or is it a notion of "life itself" that is inseparable
from its use in the biotech industry?The three sections of the book cover the three
primary activities of biotechnology today: the encoding of biological materials into
digital form -- as in bioinformatics and genomics; its recoding in various ways --
including the "biocolonialism" of mapping genetically isolated ethnic populations
and the newly pervasive concern over "biological security"; and its decoding back
into biological materiality -- as in tissue engineering and regenerative medicine.
Thacker moves easily from science to philosophy to political economics, enlivening
his account with ideas from such thinkers as Georges Bataille, Georges Canguilhem,
Michel Foucault, Antonio Negri, and Paul Virilio. The "global genome," says Thacker,
makes it impossible to consider biotechnology without the context of
globalism.

]]> http://thebiotechdictionary.com/the-global-genome-biotechnology-politics-and-culture-leonardo-book-series/feed 0